Last reviewed · How we verify
Perikabiven In Plastic Container (SODIUM GLYCEROPHOSPHATE)
Sodium Glycerophosphate, marketed as Perikabiven by Fresenius Kabi, is a phosphate replenishment therapy primarily indicated for hypophosphatemia. Its key strength lies in its patented composition, which is protected until 2028, providing a competitive edge over off-patent alternatives like sodium bicarbonate and sodium chloride. The primary risk is the presence of multiple generic competitors in the same class, such as magnesium sulfate and ammonium chloride, which could erode market share.
At a glance
| Generic name | SODIUM GLYCEROPHOSPHATE |
|---|---|
| Sponsor | Fresenius Kabi |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| First approval | 2014 |
Approved indications
- Hypophosphatemia
Common side effects
Key clinical trials
- Efficacy of Diet on Quality of Life in Multiple Sclerosis (NA)
- Topical Dexamethasone, Ascorbic Acid, and BGP for Enhancing Implant Osseointegration (NA)
- A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP) (PHASE1)
- A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E (PHASE1)
- The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in The Treatment of Hypophosphatemia in ICU Patients (PHASE2,PHASE3)
- Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning
- Effect of Probiotic Toothpaste and Regular Toothpaste on Plaque Levels of Orthodontic Patients (NA)
- Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Perikabiven In Plastic Container CI brief — competitive landscape report
- Perikabiven In Plastic Container updates RSS · CI watch RSS
- Fresenius Kabi portfolio CI